Free shipping on all orders over $ 500

Verteporfin (CL 318952)

Cat. No. M3539
Verteporfin (CL 318952) Structure
Synonym:

CL 318952; BPD-MA

Size Price Availability Quantity
2mg USD 50  USD50 In stock
5mg USD 85  USD85 In stock
10mg USD 130  USD130 In stock
25mg USD 260  USD260 In stock
50mg USD 380  USD380 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin (CL 318952) is a YAP inhibitor that disrupts YAP-TEAD interactions, and it is also an inhibitor of autophagy that blocks autophagy at an early stage by inhibiting autophagosome formation.

Verteporfin is specifically selected by PDX-cell screening. The concentrations to cause 50% growth inhibition (GI50) for PhLO, PhLH, and PhLK are 228 nM, 395 nM, and 538 nM, respectively, whereas GI50 for ALL-1, TCC-Y/sr, and NPhA1 are 3.93 µM, 2.11 µM, and 5.61 µM, respectively. GSH significantly reduces the sensitivity of 2 out of 3 PDX cells to verteporfin. Verteporfin reduces the mitochondrial membrane potential in PDX cells.

Verteporfin reduces the PTX-resistance on HCT-8/T cells by inhibiting YAP expression and combination therapy with verteporfin and NSC 125973 shows synergism on inhibition of YAP and cytotoxicity to HCT-8/T.

Chemical Information
Molecular Weight 718.79
Formula C41H42N4O8
CAS Number 129497-78-5
Solubility (25°C) DMSO 50 mg/mL
DMF 10 mg/mL (ultrasonic and warming)
Storage 2-8°C, protect from light
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Bailey V Fearing, et al. JOR Spine. Verteporfin treatment controls morphology, phenotype, and global gene expression for cells of the human nucleus pulposus

[2] Jian Chen, et al. J Cell Physiol. IL-6/YAP1/β-catenin signaling is involved in intervertebral disc degeneration

[3] Takanobu Morishita, et al. Oncotarget. The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib

[4] Yi Liu-Chittenden, et al. Genes Dev. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

[5] U Schmidt-Erfurth, et al. Surv Ophthalmol. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

Related Autophagy Products
Sofalcone

Sofalcone is a gastric antiulcer agent, it is known to induce the expression of Heme oxygenase-1 (HO-1) in gastric epithelium.

P62-mediated mitophagy inducer

P62-mediated mitophagy inducer (PMI) is a P62-mediated mitophagy activator. P62-mediated mitophagy inducer activates mitochondrial autophagy without recruitment of Parkin or collapse of the mitochondrial membrane potential and remains active in cells lacking a fully functional PINK1/Parkin pathway.

FDW028

FDW028 is a potent and highly selective FUT8 inhibitor. FDW028 exhibits potent anti-tumor activity by defucosylation and impelling lysosomal degradation of B7-H3 through the CMA pathway.

Calmodulin-Dependent Protein Kinase II (290-309)

Calmodulin-Dependent Protein Kinase II (290-309) is a potent CaMK antagonist with an IC50 of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.

Microcolin H

Microcolin H is a marine lipopeptide and phosphatidylinositol transfer protein ligand that targets PITPα/β.

  Catalog
Abmole Inhibitor Catalog




Keywords: Verteporfin (CL 318952), CL 318952; BPD-MA supplier, Autophagy, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.